Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia

References

• Alcoba-Florez J, Mendez-Alvarez S, Cano J, . Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol 2005; 43: 4107–4111.
   PubMed Web of Science ®Google Scholar
• Correia A, Sampaio P, James S, Pais C. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol 2006; 56: 313–317.
   PubMed Web of Science ®Google Scholar
• Bishop JA, Chase N, Lee R, Kurtzman CP, Merz WG. Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits. J Clin Microbiol 2008; 46: 3498–3500.
   PubMed Web of Science ®Google Scholar
• Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol 2010; 48: 1895–1899.
   PubMed Web of Science ®Google Scholar
• Bishop JA, Chase N, Magill SS, . Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J Clin Microbiol 2008; 46: 443–446.
   PubMed Web of Science ®Google Scholar
• Borman AM, Petch R, Linton CJ, . Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 2008; 46: 933–938.
   PubMed Web of Science ®Google Scholar
• Romeo O, Scordino F, Pernice I, Lo PC, Criseo G. A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J Microbiol Methods 2009; 79: 117–120.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Messer SA, Gherna M, . Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 2009; 47: 1216–1217.
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Randhawa HS, Khan ZU, . First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol 2009; 47: 1–6.
   PubMed Web of Science ®Google Scholar
• Fujita S, Senda Y, Okusi T, . Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol 2007; 45: 3459–3461.
   PubMed Web of Science ®Google Scholar
• Wahyuningsih R, SahBandar IN, Theelen B, . Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis. J Clin Microbiol 2008; 46: 388–391.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodriguez D, Park BJ, . Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829–1835.
   PubMed Web of Science ®Google Scholar
• Gomez-Lopez A, Pan D, Cuesta I, . Molecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyr. Diagn Microbiol Infect Dis 2010; 66: 116–119.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, F. Barchiesi, Subcommittee on Antifungal Susceptibility Testing (AFST). EUCAST Definitive Document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeast. Clin Microbiol Infect 2008; 14: 398–405.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother 2009; 53: 2192–2195.
   PubMed Web of Science ®Google Scholar
• Gomez-Lopez A, Zaragoza O, Rodriguez-Tudela JL, Cuenca-Estrella M. Pharmacotherapy of yeast infections. Expert Opin Pharmacother 2008; 9: 2801–2816.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Rodriguez-Tudela JL. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro. Expert Rev Anti Infect Ther 2010; 8: 267–276.
   PubMed Web of Science ®Google Scholar
• Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 197–205.
   PubMed Web of Science ®Google Scholar
• Playford EG, Lipman J, Sorrell TC. Management of invasive candidiasis in the intensive care unit. Drugs 2010; 70: 823–839.
   PubMed Web of Science ®Google Scholar
• Lewis RE. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 2009; 25: 1732–1740.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695–1703.
   PubMed Web of Science ®Google Scholar